# Fecal Microbiota Therapy Vs 5-aminosalicylates for Induction of Remission in Newly Diagnosed Mild-moderately Active UC

> **NCT03716388** · PHASE3 · UNKNOWN · sponsor: **Dayanand Medical College and Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Ulcerative Colitis Chronic Mild
- Ulcerative Colitis Chronic Moderate

## Interventions

- **BIOLOGICAL:** Fecal Microbiota Transplantation
- **DRUG:** Mesalamine Granules
- **OTHER:** Placebo infusion
- **OTHER:** Placebo granules

## Key facts

- **NCT ID:** NCT03716388
- **Lead sponsor:** Dayanand Medical College and Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-01
- **Primary completion:** 2019-12-01
- **Final completion:** 2019-12-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2019-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03716388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03716388, "Fecal Microbiota Therapy Vs 5-aminosalicylates for Induction of Remission in Newly Diagnosed Mild-moderately Active UC". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03716388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*